Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults-Reference-Cited by-同舟云学术

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults

Published:2023-09 Issue:9 Volume:12 Page:2241-2258
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Murdoch Louise,Quan Karen,Baber James A.,Ho Agnes W. Y.,Zhang Ying,Xu Xia,Lu Claire,Cooper David,Koury Kenneth,Lockhart Stephen P.,Anderson Annaliesa S.,Türeci Özlem,Şahin Uğur,Swanson Kena A.,Gruber William C.,Kitchin Nicholas,Arya Mark,Athan Eugene,Blackmore Timothy,Bull Sheetal,Edwards Andrew,Esquilant Emma,Finlay Joanne,Hamilton Paul,Hemi Tiwini,Humphrey Timothy,Kamerbeek Jackie,Kerr Jane,Kok Jen,McGirr Anthony,Montgomery Barnaby,Neville A. Munro,Quinn Dean,Sheahan Davitt,Smith Susan,Stubbs Richard,Tagelagi Maelen,Thurlow Claire,Williams Michael,Wojciechowska Joanna,

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-023-00863-5.pdf

Reference47 articles.

1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15.

2. Moreira ED Jr, Kitchin N, Xu X, et al. Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine. N Engl J Med. 2022;386:1910–21.

3. Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385:1393–400.